Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Surprising new research published in Nature found that certain obesity-associated diets improved responses to cancer immunotherapy in mice — flipping conventional wisdom on its head. The key may lie in how food interacts with gut bacteria to supercharge the immune system's ability to fight cancer. Researchers caution this isn't a green light to eat poorly, but the findings could unlock safer ways to boost immunotherapy effectiveness.
Scientists at McGill University have uncovered a surprising twist in cancer research: some diets typically labeled "unhealthy" or "fattening" actually improved the effectiveness of immune checkpoint inhibitors — a widely used form of cancer immunotherapy — in mice. The study, published in Nature, suggests the secret lies in the interplay between diet and gut microbiome composition.
The findings offer a potential new explanation for the long-puzzling "obesity paradox" in oncology, where cancer patients with higher BMIs sometimes respond better to immunotherapy. Researchers tested 12 different diets in mice and found that certain obesogenic diets boosted immunotherapy responses even over short periods — suggesting the benefit may stem from diet-microbiome interactions rather than excess body weight itself.
Key Takeaways:
Why it matters: Understanding how diet and gut bacteria work together to influence immune responses could help researchers develop targeted, safer strategies to enhance cancer immunotherapy — without the health risks tied to obesity.
